Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro

Abstract

Background and aims

Mitofusin 1 (MFN1) and MFN2 are outer mitochondrial membrane fusogenic proteins regulating mitochondrial network morphology. MFN2 mutations cause Charcot-Marie-Tooth type 2A (CMT2A), an axonal neuropathy characterized by mitochondrial fusion defects, which in the case of a GTPase domain mutant, were rescued following wild-type MFN1/2 (MFN1/2^WT) overexpression. In this study, we compared the therapeutic efficiency between MFN1^WT and MFN2^WT overexpression in correcting mitochondrial defects induced by the novel MFN2^K357T mutation located in the highly conserved R3 region.

Methods

Constructs expressing either MFN2^K357T, MFN2^WT, or MFN1^WT under the ubiquitous chicken β-actin hybrid (CBh) promoter were generated. Flag or myc tag was used for their detection. Differentiated SH-SY5Y cells were single transfected with MFN1^WT, MFN2^WT, or MFN2^K357T, as well as double transfected with MFN2^K357T/MFN2^WT or MFN2^K357T/MFN1^WT.

Results

SH-SY5Y cells transfected with MFN2^K357T exhibited severe perinuclear mitochondrial clustering with axon-like processes devoid of mitochondria. Single transfection with MFN1^WT resulted in a more interconnected mitochondrial network than transfection with MFN2^WT, accompanied by mitochondrial clusters. Double transfection of MFN2^K357T with either MFN1^WT or MFN2^WT resolved the mutant-induced mitochondrial clusters and led to detectable mitochondria throughout the axon-like processes. MFN1^WT showed higher efficacy than MFN2^WT in rescuing these defects.

Interpretation

These results further demonstrate the higher potential of MFN1^WT over MFN2^WT overexpression to rescue CMT2A-induced mitochondrial network abnormalities due to mutations outside the GTPase domain. This higher phenotypic rescue conferred by MFN1^WT, possibly due to its higher mitochondrial fusogenic ability, may be applied to different CMT2A cases regardless of the MFN2 mutation type.